Treatment patterns and clinical situation in patients with idiopathic thrombocytopenic purpura (ITP) in Japan: a retrospective claims database study

Treatment patterns and clinical situation in patients with idiopathic thrombocytopenic purpura (ITP) in Japan: a retrospective claims database study - Treatment patterns and clinical situation in patients with idiopathic thrombocytopenic purpura (ITP) in Japan: a retrospective claims database study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000052806

Enrollment

4000

Registered

2023-11-15

Start date

2023-09-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic thrombocytopenic purpura

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The study population consists of the patients diagnosed with idiopathic thrombocytopenic purpura in the DeSC Claims Database between April 2014 and August 2022 for this study

Exclusion criteria

Exclusion criteria: Patients with suspected secondary idiopathic thrombocytopenic purpura (splenomegaly, hematologic cancers, hematologic system diseases, immune disorders, malignant tumors) Patients with idiopathic thrombocytopenic purpura complicating pregnancy Patients with acute idiopathic thrombocytopenic purpura

Design outcomes

Primary

Measure	Time frame
1.Clinical situation of corticosteroid medication 2.Clinical situation of medication and treatment other than corticosteroid 3.Treatment patterns	—

Secondary

Measure	Time frame
Adverse events in corticosteroid medication	—

Countries

Japan

Contacts

Public ContactKenichi Iwayama

KISSEI PHARMACEUTICAL CO., LTD. Medical

kenichi_iwayama@pharm.kissei.co.jp03-3279-2306

Outcome results